China is positioning itself at the forefront of the next wave of global drug innovation, and artificial intelligence is emerging as the key lever that could tilt dominance in its favour. After cross-border deals for innovative drugs touched a record $110 billion in the first half of 2026, China's pharmaceutical sector is rapidly pivoting toward AI-driven drug discovery to sustain momentum. The shift signals a deeper transformation, from being a fast follower to becoming a global leader in cutting-edge therapies.Also read | <a href="https://www.wionews.com/trending/how-long-before-sun-destroys-the-earth-scientists-may-have-discovered-the-planet-s-expiry-date-1783760812774">How long before sun destroys the Earth? Scientists may have discovered the planet's 'expiry date'</a> China already accounts for roughly 30 per cent of all new drugs under development worldwide, placing it behind only the US More significantly, deal activity is accelerating. By the end of June, 81 transactions had been completed; that is nearly 80 per cent of last year’s total. It spans high-value therapeutic areas such as oncology, metabolic diseases, immunology and neurology. Global buyers, particularly from the US and Europe, continue to actively partner with Chinese firms.<a href="https://www.wionews.com/videos/china-turns-to-ai-for-next-drug-breakthroughs-1784005943869/embed">https://www.wionews.com/videos/china-turns-to-ai-for-next-drug-breakthroughs-1784005943869/embed</a>The latest collaborations highlight how AI is reshaping the innovation pipeline. Domestic companies are leveraging proprietary platforms to design molecules, simulate patient responses and optimise early-stage testing. Partnerships with global pharmaceutical majors are increasingly structured around milestone-based payouts that could run into billions of dollars. AI is enabling faster and more precise drug development by reducing reliance on traditional trial-and-error methods. Virtual modelling, predictive analytics and data-driven insights are helping companies refine candidates earlier, potentially lowering costs and shortening timelines.Also read | <a href="https://www.wionews.com/trending/built-to-outlive-us-all-earth-is-getting-an-indestructible-black-box-to-record-the-end-of-human-civilisation-1783747790087">Built to outlive us all: Earth is getting an indestructible ‘black box’ to record the end of human civilisation</a> This convergence of technology and biomedicine is strengthening China's position in the global healthcare ecosystem. Its ability to combine large datasets, advanced AI capabilities and a rapidly maturing regulatory framework is creating a powerful engine for innovation. The critical question now is whether this momentum translates into sustained global leadership. Experts say if current trends hold, China may not just participate in the next generation of medical breakthroughs; it could redefine them.

China is using artificial intelligence to discover the next generation of blockbuster medicines. With innovative drug deals hitting a record $110 billion in just six months, Beijing is positioning itself to become a global pharmaceutical powerhouse.

China is positioning itself at the forefront of the next wave of global drug innovation, and artificial intelligence is emerging as the key lever that could tilt dominance in its favour. After cross-border deals for innovative drugs touched a record $110 billion in the first half of 2026, China's pharmaceutical sector is rapidly pivoting toward AI-driven drug discovery to sustain momentum. The shift signals a deeper transformation, from being a fast follower to becoming a global leader in cutting-edge therapies. Also read | How long before sun destroys the Earth? Scientists may have discovered the planet's 'expiry date' China already accounts for roughly 30 per cent of all new drugs under development worldwide, placing it behind only the US More significantly, deal activity is accelerating. By the end of June, 81 transactions had been completed; that is nearly 80 per cent of last year’s total. It spans high-value therapeutic areas such as oncology, metabolic diseases, immunology and neurology. Global buyers, particularly from the US and Europe, continue to actively partner with Chinese firms. https://www.wionews.com/videos/china-turns-to-ai-for-next-drug-breakthroughs-1784005943869/embed The latest collaborations highlight how AI is reshaping the innovation pipeline. Domestic companies are leveraging proprietary platforms to design molecules, simulate patient responses and optimise early-stage testing. Partnerships with global pharmaceutical majors are increasingly structured around milestone-based payouts that could run into billions of dollars. AI is enabling faster and more precise drug development by reducing reliance on traditional trial-and-error methods. Virtual modelling, predictive analytics and data-driven insights are helping companies refine candidates earlier, potentially lowering costs and shortening timelines. Also read | Built to outlive us all: Earth is getting an indestructible ‘black box’ to record the end of human civilisation This convergence of technology and biomedicine is strengthening China's position in the global healthcare ecosystem. Its ability to combine large datasets, advanced AI capabilities and a rapidly maturing regulatory framework is creating a powerful engine for innovation. The critical question now is whether this momentum translates into sustained global leadership. Experts say if current trends hold, China may not just participate in the next generation of medical breakthroughs; it could redefine them.

China is using artificial intelligence to discover the next generation of blockbuster medicines. With innovative drug deals hitting a record $110 billion in just six months, Beijing is positioning itself to become a global pharmaceutical powerhouse.

China's $110-billion AI pharma boom could redefine the future of medicine

Researchers at Stanford University found that AI is also transforming scientific discovery by helping scientists to analyse complex data, generate hypotheses and formulate experiments faster than old methods. AI is entering multiple sectors, including biology, medicine, engineering, and astrophysics, to overcome limitations connected to time, resources, and data complexity. AI is also playing an increasingly significant role in biology and medicine by helping researchers analyse genetic data, identify biological patterns and develop advanced models for studying disease. According to Stanford researchers, AI-powered virtual cell models could significantly accelerate drug discovery and pave the way for more personalised healthcare.&nbsp;Also read: <a href="https://www.wionews.com/trending/japanese-researchers-found-invisible-gold-in-massive-quantities-hiding-beneath-seafloor-1783752058979">Japanese researchers find invisible gold in massive quantities hiding beneath seafloor</a><h3>Integration of AI agents</h3>AI agents are also becoming an integral part of scientific research, helping with tasks such as reviewing academic literature, designing experiments and interpreting data. However, researchers emphasise that human expertise remains indispensable, as AI-generated findings and hypotheses must still be scientifically validated and assessed for real-world applicability. From uncovering the complexities of genetic systems to exploring the structure of the universe, AI is allowing scientists to investigate questions that were previously difficult to address. Stanford researchers believe future scientific breakthroughs will rely on combining AI's computational power with human knowledge to solve increasingly complex problems. Rather than serving only as a productivity tool, AI is evolving into a fundamental component of scientific research. By analysing massive datasets, generating new hypotheses and simulating complex systems, it has the potential to accelerate discoveries across medicine, engineering, climate science and astrophysics. The findings reinforce that no matter how AI advances and enters several fields, scientific progress will continue to rely completely on human expertise. AI can speed up the process of analysis and experimentation; however, rigorous validation, ethical oversight and critical judgement will always remain vital to ensuring research results are reliable and reproducible. &nbsp;

Stanford researchers believe future scientific breakthroughs will rely on combining AI's computational power with human knowledge to solve increasingly complex problems.

Researchers at Stanford University found that AI is also transforming scientific discovery by helping scientists to analyse complex data, generate hypotheses and formulate experiments faster than old methods. AI is entering multiple sectors, including biology, medicine, engineering, and astrophysics, to overcome limitations connected to time, resources, and data complexity. AI is also playing an increasingly significant role in biology and medicine by helping researchers analyse genetic data, identify biological patterns and develop advanced models for studying disease. According to Stanford researchers, AI-powered virtual cell models could significantly accelerate drug discovery and pave the way for more personalised healthcare. Also read: Japanese researchers find invisible gold in massive quantities hiding beneath seafloor Integration of AI agents AI agents are also becoming an integral part of scientific research, helping with tasks such as reviewing academic literature, designing experiments and interpreting data. However, researchers emphasise that human expertise remains indispensable, as AI-generated findings and hypotheses must still be scientifically validated and assessed for real-world applicability. From uncovering the complexities of genetic systems to exploring the structure of the universe, AI is allowing scientists to investigate questions that were previously difficult to address. Stanford researchers believe future scientific breakthroughs will rely on combining AI's computational power with human knowledge to solve increasingly complex problems. Rather than serving only as a productivity tool, AI is evolving into a fundamental component of scientific research. By analysing massive datasets, generating new hypotheses and simulating complex systems, it has the potential to accelerate discoveries across medicine, engineering, climate science and astrophysics. The findings reinforce that no matter how AI advances and enters several fields, scientific progress will continue to rely completely on human expertise. AI can speed up the process of analysis and experimentation; however, rigorous validation, ethical oversight and critical judgement will always remain vital to ensuring research results are reliable and reproducible.

Stanford researchers believe future scientific breakthroughs will rely on combining AI's computational power with human knowledge to solve increasingly complex problems.

Can AI make scientific breakthroughs faster? Researchers weigh in

ai-in-medical

Ai In Medical, News on Ai In Medical, stories on Ai In Medical, articles on Ai In Medical, Ai In Medical stories at Wion, Ai In Medical news, Ai In Medical latest news

ai in-medical

China's $110-billion AI pharma boom could redefine the future of medicine

Can AI make scientific breakthroughs faster? Researchers weigh in